Medicare Spending on Drugs and Biologics Not Recommended for Coverage by International Health Technology Assessment Agencies
Egilman AC, Wallach JD, Dhruva SS, Gonsalves GS, Ross JS. Medicare Spending on Drugs and Biologics Not Recommended for Coverage by International Health Technology Assessment Agencies. Journal Of General Internal Medicine 2019, 34: 2319-2321. PMID: 31313117, PMCID: PMC6848610, DOI: 10.1007/s11606-019-05149-6.Peer-Reviewed Original ResearchMeSH KeywordsAustraliaBiological ProductsCanadaDrug CostsEnglandGlobal HealthHealth ExpendituresHumansInsurance CoverageMedicare Part DTechnology Assessment, BiomedicalUnited States